These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8181851)

  • 1. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
    Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
    Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
    Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
    Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
    Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
    Br J Cancer; 1991 Jul; 64(1):182-4. PubMed ID: 1854619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
    Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
    Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
    Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
    J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
    Levesque MA; Clark GM; Yu H; Diamandis EP
    Br J Cancer; 1995 Sep; 72(3):720-7. PubMed ID: 7545416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix.
    Suzuki Y; Nakano T; Arai T; Morita S; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1229-34. PubMed ID: 10889376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
    van der Burg ME; Henzen-Logmans SC; Foekens JA; Berns EM; Rodenburg CJ; van Putten WL; Klijn JG
    Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
    Johnston SR; Saccani-Jotti G; Smith IE; Salter J; Newby J; Coppen M; Ebbs SR; Dowsett M
    Cancer Res; 1995 Aug; 55(15):3331-8. PubMed ID: 7614468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
    Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C
    Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.
    Pawlowski V; Révillion F; Hebbar M; Hornez L; Peyrat JP
    Clin Cancer Res; 2000 Nov; 6(11):4217-25. PubMed ID: 11106235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
    Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
    J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
    Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
    Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.